Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase
2011

Resveratrol and Diabetic Nephropathy

Sample size: 43 publication 10 minutes Evidence: moderate

Author Information

Author(s): Chang Chih-Chun, Chang Chieh-Yu, Wu Yang-Tzu, Huang Jiung-Pang, Yen Tzung-Hai, Hung Li-Man

Primary Institution: Chang Gung University

Hypothesis

The study aimed to investigate the renoprotective effects of resveratrol and its underlying mechanisms in early-stage diabetic nephropathy.

Conclusion

Resveratrol protects against oxidative stress and modulates proinflammatory cytokines, which may contribute to its beneficial effects on early-stage diabetic nephropathy.

Supporting Evidence

  • Resveratrol treatment significantly ameliorated hyperglycemia and renal dysfunction in diabetic rats.
  • RSV reduced IL-1β but increased TNF-α and IL-6 levels in diabetic kidneys.
  • AMPK protein expression and phosphorylation were significantly rescued by RSV treatment.

Takeaway

Resveratrol, a compound found in grapes, helps protect kidneys from damage caused by diabetes by reducing stress and inflammation.

Methodology

The protective effects of resveratrol were evaluated in streptozotocin-induced diabetic rats, with various biochemical and histopathological analyses performed.

Potential Biases

Potential biases may arise from the use of a single animal model and the specific dosages of resveratrol used.

Limitations

The study was conducted on animal models, which may not fully replicate human conditions.

Participant Demographics

Male Long-Evans rats aged 6-7 weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1423-0127-18-47

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication